137 related articles for article (PubMed ID: 9770715)
21. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
Samuel AM; Rajashekharrao B; Shah DH
J Nucl Med; 1998 Sep; 39(9):1531-6. PubMed ID: 9744337
[TBL] [Abstract][Full Text] [Related]
22. [Increased sensitivity of whole-body scintigraphy with I131 for the detection of iodine-accumulating metastases by means of delayed imaging].
Briele B; Hotze A; Grünwald F; Overbeck B; Biersack HJ
Nuklearmedizin; 1990 Dec; 29(6):264-8. PubMed ID: 2075087
[TBL] [Abstract][Full Text] [Related]
23. Surveillance after treatment for well differentiated thyroid cancer: audit for chest radiography.
Powell ME; Moskovic EC; Harmer CL
Clin Oncol (R Coll Radiol); 1994; 6(3):151-3. PubMed ID: 8086348
[TBL] [Abstract][Full Text] [Related]
24. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
26. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
[TBL] [Abstract][Full Text] [Related]
27. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
29. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
30. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
31. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
[TBL] [Abstract][Full Text] [Related]
32. [Occult papillary carcinoma of the thyroid presenting as a solitary pulmonary metastasis].
Sasaki H; Sirakusa T; Suzuki K; Eimoto T; Okumura M
Nihon Naibunpi Gakkai Zasshi; 1991 Jun; 67(6):655-65. PubMed ID: 1889508
[TBL] [Abstract][Full Text] [Related]
33. 131I whole body scintigraphy in thyroid cancer patients.
Lind P
Q J Nucl Med; 1999 Sep; 43(3):188-94. PubMed ID: 10568134
[TBL] [Abstract][Full Text] [Related]
34. Inactive pulmonary tuberculosis mimicking metastasis from papillary thyroid carcinoma in diagnostic radioiodine whole-body scintigraphy.
Picolos MK; Habra M; Safdar A; Sarlis NJ
Thyroid; 2005 Sep; 15(9):1105-6. PubMed ID: 16187924
[No Abstract] [Full Text] [Related]
35. Chest computed tomography (CT) in patients with micronodular lung metastases of differentiated thyroid carcinoma.
Piekarski JD; Schlumberger M; Leclere J; Couanet D; Masselot J; Parmentier C
Int J Radiat Oncol Biol Phys; 1985 May; 11(5):1023-7. PubMed ID: 3988552
[TBL] [Abstract][Full Text] [Related]
36. [Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
Degrossi OJ; Rozados IB; Damilano S; Degrossi EB; de Ganino L; Pinkas M; García del Río H; Artagaveytía D
Medicina (B Aires); 1991; 51(4):291-5. PubMed ID: 1821916
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
38. [Significance of thyroglobulin as a tumor marker in the serum of patients with differentiated thyroid carcinoma: longitudinal and cross-sectional studies (author's transl)].
Schatz H; Grebe S; Mäser E; Teuber J; Horn W; Schröder O; Schatz C
Klin Wochenschr; 1982 May; 60(9):457-64. PubMed ID: 7045510
[TBL] [Abstract][Full Text] [Related]
39. Thyroid cancer in children and adolescents.
Ceccarelli C; Pacini F; Lippi F; Elisei R; Arganini M; Miccoli P; Pinchera A
Surgery; 1988 Dec; 104(6):1143-8. PubMed ID: 3194841
[TBL] [Abstract][Full Text] [Related]
40. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
Abduluakhab M; Gavrilov M; Mladenov B
Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]